StockData
Cytek Biosciences, Inc. logo

Cytek Biosciences, Inc. (CTKB) stock

CTKBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/309% below fair value
$5.70+0.07 (+1.24%)

Close on Nov 17, 2026Market cap $740.91MP/E –Yield –

Cytek Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Cytek Biosciences's price to sales ratio was 3.6× on Nov 11, 2026, against 3.7× a year earlier. Over the last 5 years it ranged from 1.8× to 22.5×, with a median of 4.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.6×+0.3
2025Dec 31, 20253.3×−0.9
2024Dec 31, 20244.2×−2.6
2023Dec 29, 20236.8×−2.2
2022Dec 30, 20228.9×−9.3
2021Dec 31, 202118.2×–

More Cytek Biosciences figures

See a number that looks wrong?